USA Human Chorionic Gonadotropin (HCG) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.

    The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Human Chorionic Gonadotropin (HCG) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Human Chorionic Gonadotropin (HCG) market. Detailed analysis of key players, along with key growth strategies adopted by Human Chorionic Gonadotropin (HCG) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Cigna

    • EMD Serono, Inc

    • Bristol Myers Squibb Company

    • Fresenius Kabi AG, LLC

    • Kamiya Biomedical Company

    • Leebio

    • Ferring BV

    • Scrippslabs

    • Merck & Co, Inc

    • Sanzyme

    By Type:

    • Natural Source Extraction

    • Recombinant DNA Technology

    By End-User:

    • Female Infertility Treatment

    • Oligospermic Treatment

    • Cryptorchidism Treatment

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Chorionic Gonadotropin (HCG) Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Natural Source Extraction from 2016 to 2027

      • 1.3.2 USA Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Recombinant DNA Technology from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Female Infertility Treatment from 2016 to 2027

      • 1.4.2 USA Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Oligospermic Treatment from 2016 to 2027

      • 1.4.3 USA Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Cryptorchidism Treatment from 2016 to 2027

      • 1.4.4 USA Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Human Chorionic Gonadotropin (HCG) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Human Chorionic Gonadotropin (HCG) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Human Chorionic Gonadotropin (HCG) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Human Chorionic Gonadotropin (HCG) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Human Chorionic Gonadotropin (HCG) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Human Chorionic Gonadotropin (HCG) by Major Types

      • 3.4.1 Market Size and Growth Rate of Natural Source Extraction

      • 3.4.2 Market Size and Growth Rate of Recombinant DNA Technology

    4 Segmentation of Human Chorionic Gonadotropin (HCG) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Human Chorionic Gonadotropin (HCG) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Human Chorionic Gonadotropin (HCG) in Female Infertility Treatment

      • 4.4.2 Market Size and Growth Rate of Human Chorionic Gonadotropin (HCG) in Oligospermic Treatment

      • 4.4.3 Market Size and Growth Rate of Human Chorionic Gonadotropin (HCG) in Cryptorchidism Treatment

      • 4.4.4 Market Size and Growth Rate of Human Chorionic Gonadotropin (HCG) in Others

    5 Market Analysis by Regions

    • 5.1 USA Human Chorionic Gonadotropin (HCG) Production Analysis by Regions

    • 5.2 USA Human Chorionic Gonadotropin (HCG) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Human Chorionic Gonadotropin (HCG) Landscape Analysis

    • 6.1 West USA Human Chorionic Gonadotropin (HCG) Landscape Analysis by Major Types

    • 6.2 West USA Human Chorionic Gonadotropin (HCG) Landscape Analysis by Major End-Users

    7 South USA Human Chorionic Gonadotropin (HCG) Landscape Analysis

    • 7.1 South USA Human Chorionic Gonadotropin (HCG) Landscape Analysis by Major Types

    • 7.2 South USA Human Chorionic Gonadotropin (HCG) Landscape Analysis by Major End-Users

    8 Middle West USA Human Chorionic Gonadotropin (HCG) Landscape Analysis

    • 8.1 Middle West USA Human Chorionic Gonadotropin (HCG) Landscape Analysis by Major Types

    • 8.2 Middle West USA Human Chorionic Gonadotropin (HCG) Landscape Analysis by Major End-Users

    9 Northeast USA Human Chorionic Gonadotropin (HCG) Landscape Analysis

    • 9.1 Northeast USA Human Chorionic Gonadotropin (HCG) Landscape Analysis by Major Types

    • 9.2 Northeast USA Human Chorionic Gonadotropin (HCG) Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Cigna

        • 10.1.1 Cigna Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 EMD Serono, Inc

        • 10.2.1 EMD Serono, Inc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Bristol Myers Squibb Company

        • 10.3.1 Bristol Myers Squibb Company Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Fresenius Kabi AG, LLC

        • 10.4.1 Fresenius Kabi AG, LLC Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Kamiya Biomedical Company

        • 10.5.1 Kamiya Biomedical Company Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Leebio

        • 10.6.1 Leebio Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Ferring BV

        • 10.7.1 Ferring BV Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Scrippslabs

        • 10.8.1 Scrippslabs Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Merck & Co, Inc

        • 10.9.1 Merck & Co, Inc Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Sanzyme

        • 10.10.1 Sanzyme Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Natural Source Extraction from 2016 to 2027

    • Figure USA Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Recombinant DNA Technology from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Female Infertility Treatment from 2016 to 2027

    • Figure USA Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Oligospermic Treatment from 2016 to 2027

    • Figure USA Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Cryptorchidism Treatment from 2016 to 2027

    • Figure USA Human Chorionic Gonadotropin (HCG) Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Human Chorionic Gonadotropin (HCG) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Human Chorionic Gonadotropin (HCG) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Human Chorionic Gonadotropin (HCG) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Human Chorionic Gonadotropin (HCG) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Human Chorionic Gonadotropin (HCG) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Human Chorionic Gonadotropin (HCG)

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Human Chorionic Gonadotropin (HCG) by Different Types from 2016 to 2027

    • Table Consumption Share of Human Chorionic Gonadotropin (HCG) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Natural Source Extraction

    • Figure Market Size and Growth Rate of Recombinant DNA Technology

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Human Chorionic Gonadotropin (HCG) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Human Chorionic Gonadotropin (HCG) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Female Infertility Treatment

    • Figure Market Size and Growth Rate of Oligospermic Treatment

    • Figure Market Size and Growth Rate of Cryptorchidism Treatment

    • Figure Market Size and Growth Rate of Others

    • Table USA Human Chorionic Gonadotropin (HCG) Production by Regions

    • Table USA Human Chorionic Gonadotropin (HCG) Production Share by Regions

    • Figure USA Human Chorionic Gonadotropin (HCG) Production Share by Regions in 2016

    • Figure USA Human Chorionic Gonadotropin (HCG) Production Share by Regions in 2021

    • Figure USA Human Chorionic Gonadotropin (HCG) Production Share by Regions in 2027

    • Table USA Human Chorionic Gonadotropin (HCG) Consumption by Regions

    • Table USA Human Chorionic Gonadotropin (HCG) Consumption Share by Regions

    • Figure USA Human Chorionic Gonadotropin (HCG) Consumption Share by Regions in 2016

    • Figure USA Human Chorionic Gonadotropin (HCG) Consumption Share by Regions in 2021

    • Figure USA Human Chorionic Gonadotropin (HCG) Consumption Share by Regions in 2027

    • Table West USA Human Chorionic Gonadotropin (HCG) Consumption by Types from 2016 to 2027

    • Table West USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types from 2016 to 2027

    • Figure West USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types in 2016

    • Figure West USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types in 2021

    • Figure West USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types in 2027

    • Table West USA Human Chorionic Gonadotropin (HCG) Consumption by End-Users from 2016 to 2027

    • Table West USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users in 2016

    • Figure West USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users in 2021

    • Figure West USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users in 2027

    • Table South USA Human Chorionic Gonadotropin (HCG) Consumption by Types from 2016 to 2027

    • Table South USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types from 2016 to 2027

    • Figure South USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types in 2016

    • Figure South USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types in 2021

    • Figure South USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types in 2027

    • Table South USA Human Chorionic Gonadotropin (HCG) Consumption by End-Users from 2016 to 2027

    • Table South USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users in 2016

    • Figure South USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users in 2021

    • Figure South USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users in 2027

    • Table Middle West USA Human Chorionic Gonadotropin (HCG) Consumption by Types from 2016 to 2027

    • Table Middle West USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types in 2016

    • Figure Middle West USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types in 2021

    • Figure Middle West USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types in 2027

    • Table Middle West USA Human Chorionic Gonadotropin (HCG) Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users in 2016

    • Figure Middle West USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users in 2021

    • Figure Middle West USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users in 2027

    • Table Northeast USA Human Chorionic Gonadotropin (HCG) Consumption by Types from 2016 to 2027

    • Table Northeast USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types in 2016

    • Figure Northeast USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types in 2021

    • Figure Northeast USA Human Chorionic Gonadotropin (HCG) Consumption Share by Types in 2027

    • Table Northeast USA Human Chorionic Gonadotropin (HCG) Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users in 2016

    • Figure Northeast USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users in 2021

    • Figure Northeast USA Human Chorionic Gonadotropin (HCG) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Cigna

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cigna

    • Figure Sales and Growth Rate Analysis of Cigna

    • Figure Revenue and Market Share Analysis of Cigna

    • Table Product and Service Introduction of Cigna

    • Table Company Profile and Development Status of EMD Serono, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EMD Serono, Inc

    • Figure Sales and Growth Rate Analysis of EMD Serono, Inc

    • Figure Revenue and Market Share Analysis of EMD Serono, Inc

    • Table Product and Service Introduction of EMD Serono, Inc

    • Table Company Profile and Development Status of Bristol Myers Squibb Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol Myers Squibb Company

    • Figure Sales and Growth Rate Analysis of Bristol Myers Squibb Company

    • Figure Revenue and Market Share Analysis of Bristol Myers Squibb Company

    • Table Product and Service Introduction of Bristol Myers Squibb Company

    • Table Company Profile and Development Status of Fresenius Kabi AG, LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fresenius Kabi AG, LLC

    • Figure Sales and Growth Rate Analysis of Fresenius Kabi AG, LLC

    • Figure Revenue and Market Share Analysis of Fresenius Kabi AG, LLC

    • Table Product and Service Introduction of Fresenius Kabi AG, LLC

    • Table Company Profile and Development Status of Kamiya Biomedical Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kamiya Biomedical Company

    • Figure Sales and Growth Rate Analysis of Kamiya Biomedical Company

    • Figure Revenue and Market Share Analysis of Kamiya Biomedical Company

    • Table Product and Service Introduction of Kamiya Biomedical Company

    • Table Company Profile and Development Status of Leebio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Leebio

    • Figure Sales and Growth Rate Analysis of Leebio

    • Figure Revenue and Market Share Analysis of Leebio

    • Table Product and Service Introduction of Leebio

    • Table Company Profile and Development Status of Ferring BV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring BV

    • Figure Sales and Growth Rate Analysis of Ferring BV

    • Figure Revenue and Market Share Analysis of Ferring BV

    • Table Product and Service Introduction of Ferring BV

    • Table Company Profile and Development Status of Scrippslabs

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Scrippslabs

    • Figure Sales and Growth Rate Analysis of Scrippslabs

    • Figure Revenue and Market Share Analysis of Scrippslabs

    • Table Product and Service Introduction of Scrippslabs

    • Table Company Profile and Development Status of Merck & Co, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co, Inc

    • Figure Revenue and Market Share Analysis of Merck & Co, Inc

    • Table Product and Service Introduction of Merck & Co, Inc

    • Table Company Profile and Development Status of Sanzyme

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanzyme

    • Figure Sales and Growth Rate Analysis of Sanzyme

    • Figure Revenue and Market Share Analysis of Sanzyme

    • Table Product and Service Introduction of Sanzyme


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.